Dynamic First Pass 3D EPI of the Prostate: Accuracy in Tumor Location

References

• Altman DG. Inter-rater agreement. In: Practical statistics for medical research. Boca Raton, London, New York, Washington D.C.: Chapman & Hall/CRC; 1991:403–9.
   Google Scholar
• Bhujwalla ZM, Artemov D, Natarajan K, Ackerstaff E, Solaiyappan M. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 2001;3:143–53.
   Google Scholar
• Brown G, Macvicar DA, Ayton V, Husband JE. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 1995;50:601–6.
   PubMed Web of Science ®Google Scholar
• Engelbrecht M, Huisman HJ, Barentz J, Van Leenders G, van der Sanden B, de la Rosette JJMCH. Potentials of kinetic parameters for differentiation of prostate cancer and peripheral zone using dynamic MRI. Proc Int Mag Reson Med 2000;8:1433.
   Google Scholar
• Fan X, River JN, Zamora M, Tarlo K, Kellar K, Rinker-Schaeffer C, et al. Differentiation of nonmeta-static and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med 2001;45:1046–55.
   Google Scholar
• Fleiss JL. The measurement of interrater agreement. In: Statistical methods for rates and proportions, 2nd edn. New York, Chichester, Brisbane, Toronto, Singapore: John Wiley & Sons; 1981:212–36.
   Google Scholar
• Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992;23:273–9.
   PubMed Web of Science ®Google Scholar
• Griebel J, Hess CF, Schmiedl U, Koelbel G. MR characteristics of prostatic carcinoma and benign prostatic hyperplasia at 1.5T. J Comput Assist Tomogr 1988;12:988–94.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29–36.
   PubMed Web of Science ®Google Scholar
• Huch Böni RA, Boner JA, Liitolf UM, Trinkler F, Pestalozzi DM, Krestin GP. Contrast-enhanced endor-ectal coil MRI in local staging of prostate carcinoma. J Comput Assist Tomogr 1995;19:232–7.
   Google Scholar
• Ikonen S, Kärkkäinen P, Kivisaari L, Salo JO, Taari K, 18. Vehmas T, et al. Magnetic resonance imaging of pros-tatic cancer: Does detection vary between high and low Gleason score tumors? Prostate 2000;43: 43–8.19.
   Google Scholar
• Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, et al. Dynamic turbo FLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histo- apathologic results. Radiology 1997;203:645-52.20.
   Google Scholar
• Koh TS, Cheong LH, Hou Z, Soh YC. A physiologic model of capillary-tissue exchange for dynamic contrast-enhanced imaging of tumor microcirculation. IEEE Trans Biomed Eng 2003;50:159-67.21.
   Google Scholar
• Liney GP, Turnbull W, Knowles AJ. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed 1999;12: 39–44.
   Google Scholar
• Mirowitz SA, Brown JJ, Heiken JP. Evaluation of the prostate and prostatic carcinoma with gadolinium- 22. enhanced endorectal coil MR imaging. Radiology 1993; 186:153–7.
   Google Scholar
• Ogura K, Maekawa S, Okubo K, Aoki Y, Okada T, Oda K, et al. Dynamic endorectal magnetic resonance 23. imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 2001;57: 721–6.
   Google Scholar
• Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, et al. Dynamic contrast-enhanced MRI of prostate cancer: correlation with morphology and tumor stage, histological grade and PSA. Clin Radiol 2000;55:99–109.
   PubMed Web of Science ®Google Scholar
• Preziosi P, Orlacchio A, Giambattista GD. Enhance-ment patterns of prostate cancer in dynamic MRI. Eur Radiol 2003;13:925–30.
   Google Scholar
• Quint LE, Van Erp JS, Bland PH, Del Buono EA, Mandell SH, Grossman HB, et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. Radiology 1991;179: 837–42.
   PubMed Web of Science ®Google Scholar
• Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993;189:339–52.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Samma S, Joko M, Akiyama T, Takewa M, Kitano S, et al. Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast-enhancement in patients with localized prostate cancer: mapping studies with biopsy specimens. Int J Urol 1999;6:593–9.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357–67.
   Google Scholar
• Turnbull LW, Buckley DL, Turnbull LS, Liney GP, Knowles AJ. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic GD-DTPA-enhanced MR imaging and histo-pathology. J Magn Reson Imaging 1999;9:311–6.
   Google Scholar